<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Diabetes Res Clin Pract</span><span class="iso-abbrev" title="iso-abbrev">Diabetes Res. Clin. Pract</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Diabetes Research and Clinical Practice</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0168-8227</span><span class="issn-epub" tagx="issn" title="issn-epub">1872-8227</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Elsevier B.V.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7445120">7445120</a></span><span class="publisher-id" title="publisher-id">S0168-8227(20)30639-2</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.diabres.2020.108386">10.1016/j.diabres.2020.108386</a></span><span class="publisher-id" title="publisher-id">108386</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
The association of diabetes and the prognosis of COVID-19 patients: A retrospective study</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Zhelong</span></span><a href="#af005">a</a><a href="#fn1">1</a><a href="#cor1">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bai</span><span class="given-names" tagx="given-names" title="given-names">Xi</span></span><a href="#af010">b</a><a href="#fn1">1</a><a href="#cor1">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">Xia</span></span><a href="#af005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">Wangyan</span></span><a href="#af005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qiu</span><span class="given-names" tagx="given-names" title="given-names">Lin</span></span><a href="#af015">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Shi</span></span><a href="#af010">b</a><a href="#cor1">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">Xuefeng</span></span><a href="#af005">a</a><a href="#cor1">â�Ž</a></span><span class="citation_author_institution" id="af005">[a], </span><span class="citation_author_institution" id="af010">[b], </span><span class="citation_author_institution" id="af015">[c], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Corresponding authors.</div> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">1</span><p id="np020">Zhelong Liu and Xi Bai contributed equally to this article.</p> </div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-8-8</span></span><span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2020-11</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-8-8</span></span><span class="volume" tagx="volume" title="volume">169</span><span class="fpage" tagx="fpage" title="fpage">108386</span><span class="lpage" tagx="lpage" title="lpage">108386</span><span class="history" title="history"><span class="received" title="received">received: 2020-7-22</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-8-6</span><span class="accepted" title="accepted">accepted: 2020-8-20</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder" />, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> <div class="abstract" title="abstract"> <div class="title" tagx="title" title="title">
Highlights</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0005">COVID-19 patients with poorly-controlled HbA1c showed increased worsening rate.</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0010">A HbA1c level of 8.6% (70 mmol/mol) was the optimal cutoff value.</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0015">Antidiabetic/antihypertensive drug use was not related to worsening in COVID-19 patients.</p> </li> </ul> <p /> </div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="aims" title="sec"> <div class="title" tagx="title" title="title">
Aims</div> <p>This study evaluated the impact of previous glycemic control and in-hospital use of antidiabetic/antihypertensive drugs on the prognosis of COVID-19 patients with diabetes.</p> </div> <div class="methods" title="sec"> <div class="title" tagx="title" title="title">
Methods</div> <p>In this retrospective cohort study, consecutive inpatients with laboratory confirmed COVID-19 were enrolled from Tongji Hospital (Wuhan, China). Patients without diabetes were matched to those with diabetes based on age, sex, and comorbidities. All patients were followed up to a clinical endpoint (discharge, worsening including transferring to ICU or immediate death). Data and outcomes were extracted from medical records and analyzed.</p> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <p>64 patients with pre-existing diabetes were included in this study, with 128 matched patients without diabetes included as a control group. Patients with diabetes had a higher rate of worsening (18.8% versus 7.8%, pÂ =Â 0.025). Multivariable regression showed increased odds of worsening associated with previous glycemic control reflected by HbA1c (odds ratio 3.29, 95% CI 1.19â€"9.13, pÂ =Â 0.022) and receiver-operating characteristics (ROC) curve identified HbA1c of 8.6% (70Â mmol/mol) as the optimal cut-off value. Univariate analysis demonstrated the in-hospital use of antidiabetic/antihypertensive drugs were not associated with a higher risk of worsening.</p> </div> <div class="conclusions" title="sec"> <div class="title" tagx="title" title="title">
Conclusions</div> <p>COVID-19 patients with diabetes had a higher risk of worsening, especially those with poorly-controlled HbA1c, with an optimal cut-off value of 8.6%. The in-hospital use of antidiabetic/antihypertensive drugs were not associated with increased odds of worsening in patients with diabetes.</p> </div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Antidiabetic drugs</div> <div class="kwd" title="kwd">
Antihypertensive drugs</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
Diabetes</div> <div class="kwd" title="kwd">
HbA1c</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Abbreviations</div> <div class="kwd" title="kwd">
ACE-2, Angiotensin-converting enzyme 2</div> <div class="kwd" title="kwd">
ACEI, Angiotensin-converting enzyme inhibitor</div> <div class="kwd" title="kwd">
ARB, Angiotensin II receptor 1 blocker</div> <div class="kwd" title="kwd">
BG, Blood glucose</div> <div class="kwd" title="kwd">
CCB, Calcium channel blocker</div> <div class="kwd" title="kwd">
cTnI, Cardiac troponin I</div> <div class="kwd" title="kwd">
CRP, C-reactive protein</div> <div class="kwd" title="kwd">
DM, Diabetes mellitus</div> <div class="kwd" title="kwd">
HbA1c, Glycated hemoglobin A1c</div> <div class="kwd" title="kwd">
ICU, Intensive care unit</div> <div class="kwd" title="kwd">
COVID-19, Novel coronavirus disease 2019</div> <div class="kwd" title="kwd">
NT-proBNP, N-terminal brain natriuretic peptide precursor</div> <div class="kwd" title="kwd">
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2</div> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1</span><div class="title" tagx="title" title="title">
Introduction</div> <p id="p0020">Since Dec 2019, the novel coronavirus disease 2019 (COVID-19) has spread rapidly around the world and infected &amp;gt;10 million people hitherto <a href="#b0005">[1]</a>. The pathogen was identified as a novel, highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can invade the human body through angiotensin-converting enzyme 2 (ACE-2) <a href="#b0010">[2]</a>. The clinical manifestations of COVID-19 include fever, dry cough, dyspnea, myalgia, fatigue etc, and severe cases can rapidly develop into acute respiratory distress syndrome, septic shock, and multiple organ dysfunction syndrome <a href="#b0015">[3]</a>.</p> <p id="p0025">Recent studies have shown that diabetes mellitus (DM) is one of the most common comorbidities of COVID-19, with a prevalence ranging from 5.3% to 58.0% <a href="#b0020">[4]</a>, <a href="#b0025">[5]</a>, <a href="#b0030">[6]</a>. Diabetes has been associated with an increased mortality in previous viral epidemics, such as the outbreak of SARS-CoV-1 and Middle East respiratory syndrome coronavirus <a href="#b0035">[7]</a>, <a href="#b0040">[8]</a>. Similar conclusions were reported in the pandemic of SARS-CoV-2. Some studies have suggested that diabetes is a risk factor for the poor prognosis of COVID-19 <a href="#b0020">[4]</a>, <a href="#b0045">[9]</a>, <a href="#b0050">[10]</a>, while some studies reported that patients with diabetes seemed not to have a higher mortality risk <a href="#b0055">[11]</a>, <a href="#b0060">[12]</a>. Data regarding the impact of diabetes on the prognosis of COVID-19 patients are scant and controversial.</p> <p id="p0030">Good glycemic control should be the most important for patients with diabetes during the COVID-19 infection as it has been shown to improve the innate immune system <a href="#b0065">[13]</a>, <a href="#b0070">[14]</a>. Data from other viral epidemics such as SARS and influenza H1N1 has demonstrated that patients with poor glycemic control have a higher mortality risk <a href="#b0035">[7]</a>, <a href="#b0075">[15]</a>. Unfortunately, the previous studies mostly focused on the impact of diabetes, as a comorbidity, on the prognosis of COVID-19. Despite a few studies reported that COVID-19 patients with poorly controlled fasting blood glucose in hospital were associated with higher mortality <a href="#b0080">[16]</a>, there is still a lack of information on the impact of previous glycemic control on the prognosis of COVID-19 patients with diabetes. In addition, previous studies have reported that metformin could increase ACE-2 expression and improve its stability by impeding its ubiquitination and proteasomal degradation <a href="#b0085">[17]</a>. Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor 1 blockers (ARB) also have been considered as a link between COVID-19 and diabetes because they are widely used in patients with diabetes <a href="#b0090">[18]</a>. However, there are still no solid evidences demonstrating the impact of these medications on the prognosis of this population.</p> <p id="p0035">In this report, we aimed to evaluate the prognosis of COVID-19 patients with diabetes and the impact of previous glycemic control on it. Besides, the influence of the commonly used antidiabetic and antihypertensive drugs on the prognosis of patients with diabetes was also explored.</p> </div> <div class="methods" title="sec"><span class="label" tagx="label" title="label">2</span><div class="title" tagx="title" title="title">
Methods</div> <div class="studydesignandpopulation" title="sec"><span class="label" tagx="label" title="label">2.1</span><div class="title" tagx="title" title="title">
Study design and population</div> <p id="p0040">This retrospective cohort study included consecutive confirmed COVID-19 inpatients from Guanggu branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China), a designated hospital for the treatment of COVID-19 patients. Patients were admitted from February 3, 2020 to February 26, 2020. SARS-CoV-2 infection was confirmed in all patients based on reverse transcription-polymerase chain reaction according to the criteria of the New Coronavirus Pneumonia Prevention and Control Program (5th edition) published by the National Health Commission of China <a href="#b0095">[19]</a>. Patients with diabetes were designated according to the patientâ€™s medical history. Then the patients without diabetes were matched (2:1 ratio) to the patients with diabetes based on age, sex, and comorbidities (hypertension, hyperlipemia, chronic renal diseases). The study was approved by the Ethics Committee of Tongji Hospital (TJ-IRB20200404). Written informed consent forms were waived in the urgency of pandemic.</p> </div> <div class="datacollection" title="sec"><span class="label" tagx="label" title="label">2.2</span><div class="title" tagx="title" title="title">
Data collection</div> <p id="p0045">A trained team of physicians extracted the epidemiological, demographic, clinical, laboratory, treatment, and prognosis data from electronic medical records. The demographic characteristics, comorbidities, clinical symptoms, symptoms from onset to admission, vital signs, laboratory findings, antidiabetic and antihypertensive drugs used prior to admission and during hospitalization, and outcomes were collected. Most of the clinical data used in our study were collected from the first day of admission unless otherwise stated. Comorbidities were determined based on the patientâ€™s self-report on admission. The glycated hemoglobin A1c (HbA1c) and the maximum of the blood glucose (BG) in-hospital were used to reflect the previous and in-hospital glycemic control, respectively. All data were double-checked by different researchers to guarantee the accuracy. All patients were followed up to a clinical endpoint (discharge, worsening including transferring to intensive care unit (ICU) or immediate death). Patients who transferred to ICU or died immediately before transferring to ICU were classified as the worsening group.</p> </div> <div class="statisticalanalysis" title="sec"><span class="label" tagx="label" title="label">2.3</span><div class="title" tagx="title" title="title">
Statistical analysis</div> <p id="p0050">Continuous and categorical variables were described as median (interquartile range [IQR]) and number (%), respectively. Continuous variables between groups were compared by the Mann-Whitney <i>U</i> test, and categorical variables were compared by Chi-square or Fisherâ€™s exact test where appropriate.</p> <p id="p0055">Binary logistic regression models were used to evaluate the impact of the previous and in-hospital glycemic control on the outcomes of the patients with diabetes, and three models were constructed to adjust potential confounding factors. Model 1 explored the risk factors associated with worsening by a univariate analysis, which included HbA1c, maximum of the BG in-hospital, age, sex, smoking, comorbidities other than diabetes, white cell count, the percentage of neutrophils, lymphopenia, alanine aminotransferase, aspartate aminotransferase, Î³-glutamyl transferase, creatinine, C-reactive protein (CRP), D-dimer, N-terminal brain natriuretic peptide precursor (NT-proBNP), cardiac troponin I (cTnI), prothrombin time, total cholesterol, triglyceride, interleukin-6, tumor necrosis factor-Î±. Model 2 included HbA1c and the maximum of the BG in-hospital for a multivariate logistic regression analysis. On the basis of model 2, the variables with a P valueÂ <div class="â_UNKNOWN"> </div></p><p id="p0060">Receiver operating characteristic (ROC) curve was used to analyze the predictive value of the HbA1c level on the prognosis of the patients with diabetes. When we evaluated the association between the use of each antidiabetic or antihypertensive drug and the outcomes, due to the limited number of patients in each subset, logistic regression model was used and only glucose, HbA1c at admission or maximum of the glucose in-hospital were adjusted to avoid over-fitting. The results were shown in odds ratio (OR) and 95% confidence interval (CI). A two-sided P valueÂ <div class="â_UNKNOWN"> </div></p></div> </div> <div class="results" title="sec"><span class="label" tagx="label" title="label">3</span><div class="title" tagx="title" title="title">
Results</div> <div class="demographicsandcharacteristics" title="sec"><span class="label" tagx="label" title="label">3.1</span><div class="title" tagx="title" title="title">
Demographics and characteristics</div> <p id="p0065">A total of 64 confirmed COVID-19 patients with pre-existing DM were included in this study (<a href="#t0005">Table 1</a> ). 128 COVID-19 patients without diabetes were included as a control group, closely matched for age, sex and comorbidities. The median age of the patients with diabetes was 66.0Â years (IQR, 59.0â€"71.0), and 35 (54.7%) were male. 39 (60.9%) patients with diabetes had at least one other comorbidities, with hypertension (37 [57.8%]) being the most common comorbidity. The median duration from the symptom onset to admission was 10.0Â days (IQR, 7.0â€"15.0) for patients with diabetes and 14.0Â days (IQR, 8.0â€"17.0) for patients without diabetes. The most common symptoms for both groups were fever and cough, followed by fatigue and diarrhea (<a href="#t0005">Table 1</a>). The patients with diabetes reported a significantly higher incidence of fever (76.6% versus 61.7%) compared to the group without diabetes. <div class="table-wrap_UNKNOWN" position="float" id="t0005"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>Demographics and baseline characteristics of COVID-19 patients with or without a history of diabetes.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th>Parameters</th> <th>Without diabetes<br /><br />(nÂ =Â 128)</th> <th>With diabetes<br /><br />(nÂ =Â 64)</th> <th>P value</th> </tr> </thead> <tbody> <tr> <td>Age, years</td> <td>67.0 (59.3â€"71.0)</td> <td>66 (59.0â€"71.0)</td> <td>0.998</td> </tr> <tr> <td>Male gender</td> <td>69 (53.9%)</td> <td>35 (54.7%)</td> <td>0.830</td> </tr> <tr> <td>Female gender</td> <td>59 (46.1%)</td> <td>29 (45.3%)</td> <td>â€"â€"</td> </tr> <tr> <td>Comorbidities on Admission</td> <td>79 (61.7%)</td> <td>39 (60.9%)</td> <td>0.916</td> </tr> <tr> <td>Hypertension</td> <td>76 (59.4%)</td> <td>37 (57.8%)</td> <td>0.836</td> </tr> <tr> <td>Hyperlipemia</td> <td>9 (7.0%)</td> <td>5 (7.8%)</td> <td>1.000</td> </tr> <tr> <td>Chronic renal diseases</td> <td>1 (0.8%)</td> <td>0 (0.0%)</td> <td>1.000</td> </tr> <tr> <td colspan="4">Smoking status</td> </tr> <tr> <td>Never/unknown</td> <td>109 (85.2%)</td> <td>56 (87.5%)</td> <td>0.660</td> </tr> <tr> <td>Former/current</td> <td>19 (14.8%)</td> <td>8 (12.5%)</td> <td>â€"â€"</td> </tr> <tr> <td colspan="4">Clinical characteristics on admission</td> </tr> <tr> <td>Systolic pressure, mmHg</td> <td>132.0 (119.5â€"145.0)</td> <td>133.5 (120.0â€"145.8)</td> <td>0.695</td> </tr> <tr> <td>Diastolic pressure, mmHg</td> <td>78.0 (70.0â€"86.5)</td> <td>78.5 (70.0â€"87.8)</td> <td>0.873</td> </tr> <tr> <td>Pulse oxygen saturation, %</td> <td>95.0 (95.0â€"95.0)</td> <td>95.0 (95.0â€"95.0)</td> <td>0.529</td> </tr> <tr> <td>Duration from onset to admission, days</td> <td>14.0 (8.0â€"17.0)</td> <td>10.0 (7.0â€"15.0)</td> <td>0.145</td> </tr> <tr> <td>Fever</td> <td>79 (61.7%)</td> <td>49 (76.6%)</td> <td>0.040</td> </tr> <tr> <td>Highest temperature, â"ƒ</td> <td>38.3 (37.8â€"39.0)</td> <td>38.5 (38.0â€"38.9)</td> <td>0.573</td> </tr> <tr> <td>Fatigue</td> <td>30 (23.4%)</td> <td>15 (23.4%)</td> <td>1.000</td> </tr> <tr> <td>Cough</td> <td>88 (68.8%)</td> <td>41 (64.1%)</td> <td>0.514</td> </tr> <tr> <td>Snot</td> <td>0 (0.0%)</td> <td>0 (0.0%)</td> <td>â€"â€"</td> </tr> <tr> <td>Myalgia</td> <td>16 (12.5%)</td> <td>6 (9.4%)</td> <td>0.522</td> </tr> <tr> <td>Diarrhea</td> <td>21 (16.4%)</td> <td>11 (17.2%)</td> <td>0.891</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Data are presented as numbers (%) or median [25thâ€"75th percentile].</p> </div> </div>  <p /> </div> <div class="laboratoryindicesandclinicaloutcomes" title="sec"><span class="label" tagx="label" title="label">3.2</span><div class="title" tagx="title" title="title">
Laboratory indices and clinical outcomes</div> <p id="p0070">Laboratory findings on admission and clinical outcomes of both groups are summarized in <a href="#t0010">Table 2</a> . The rate of disease worsening during hospitalization was significantly higher in the patients with pre-existing DM compared to the patients without diabetes (18.8% versus 7.8%, pÂ =Â 0.025). Compared to the group without diabetes, patients with diabetes presented higher BG level as expected (8.6Â mmol/L [6.5â€"15.6] versus 5.7Â mmol/L [5.2â€"7.1]), with higher levels of HbA1c (8.1% [65Â mmol/mol] versus 6.3% [45Â mmol/mol]). The white cell count and the percentage of neutrophils were significantly higher in patients with diabetes. Moreover, patients with diabetes demonstrated a significantly higher incidence of lymphopenia (53.1% versus 33.6%). As for the inflammatory markers, the CRP level was significantly higher in the group with diabetes (39.3Â mg/L [2.9â€"72.3] versus 7.6Â mg/L [1.6â€"31.6]) while the procalcitonin level showed no difference between the two groups. Besides, patients with diabetes showed a higher level of the NT-proBNP. <div class="table-wrap_UNKNOWN" position="float" id="t0010"><span class="label" tagx="label" title="label">Table 2</span> </div></p><p>Initial laboratory examination and outcomes of COVID-19 patients with or without a history of diabetes.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th>Parameters</th> <th>Without diabetes<br /><br />(nÂ =Â 128)</th> <th>With diabetes<br /><br />(nÂ =Â 64)</th> <th>P value</th> </tr> </thead> <tbody> <tr> <td>White cell count, Ã— 10<sup>9</sup>/L</td> <td>5.3 (4.3â€"6.8)</td> <td>6.1 (5.1â€"8.8)</td> <td>0.002</td> </tr> <tr> <td>&amp;lt; 4</td> <td>24 (18.8%)</td> <td>6 (9.4%)</td> <td>0.092</td> </tr> <tr> <td>4â€"10</td> <td>95 (74.2%)</td> <td>45 (70.3%)</td> <td>â€"â€"</td> </tr> <tr> <td>&amp;gt; 10</td> <td>7 (5.5%)</td> <td>13 (20.3%)</td> <td>â€"â€"</td> </tr> <tr> <td>Neutrophils, %</td> <td>64.0 (56.1â€"73.2)</td> <td>73.5 (60.7â€"82.8)</td> <td>0.001</td> </tr> <tr> <td>Lymphocyte, %</td> <td>24.2 (17.8â€"31.4)</td> <td>17.1 (10.2â€"26.2)</td> <td>0.001</td> </tr> <tr> <td>&amp;lt; 20</td> <td>43 (33.6%)</td> <td>34 (53.1%)</td> <td>0.009</td> </tr> <tr> <td>â‰¥20</td> <td>83 (64.8%)</td> <td>30 (46.9%)</td> <td>â€"â€"</td> </tr> <tr> <td>Monocytes, %</td> <td>9.4 (7.4â€"11.8)</td> <td>8.3 (6.6â€"10.2)</td> <td>0.002</td> </tr> <tr> <td>Hemoglobin, g/L</td> <td>125.5 (116.0â€"135.0)</td> <td>128.0 (115.0â€"138.0)</td> <td>0.257</td> </tr> <tr> <td>Platelet count, Ã— 10<sup>9</sup>/L</td> <td>258.0 (181.5â€"332.0)</td> <td>237.0 (188.0â€"323.0)</td> <td>0.849</td> </tr> <tr> <td>Alanine aminotransferase, U/L</td> <td>20.0 (13.0â€"33.0)</td> <td>23.0 (13.3â€"37.0)</td> <td>0.534</td> </tr> <tr> <td>Aspartate aminotransferase, U/L</td> <td>23.0 (18.0â€"33.0)</td> <td>25.0 (17.3â€"35.5)</td> <td>0.479</td> </tr> <tr> <td>Alkaline phosphatase, U/L</td> <td>66.5 (56.3â€"78.8)</td> <td>67.0 (57.3â€"84.0)</td> <td>0.614</td> </tr> <tr> <td>Î³-glutamyl transferase, U/L</td> <td>23.5 (16.0â€"37.5)</td> <td>27.0 (17.3â€"64.0)</td> <td>0.089</td> </tr> <tr> <td>Total bilirubin, mmol/L</td> <td>7.8 (5.8â€"11.1)</td> <td>8.0 (5.9â€"11.8)</td> <td>0.522</td> </tr> <tr> <td>Creatinine, Î¼mol/L</td> <td>71.0 (59.0â€"84.0)</td> <td>68.5 (53.8â€"87.5)</td> <td>0.618</td> </tr> <tr> <td>Urea nitrogen, mmol/L</td> <td>4.5 (3.6â€"5.6)</td> <td>5.3 (3.9â€"6.8)</td> <td>0.030</td> </tr> <tr> <td>Glomerular filtration rate, mL/min</td> <td>90.2 (74.5â€"97.3)</td> <td>90.5 (75.1â€"101.5)</td> <td>0.514</td> </tr> <tr> <td>C-reactive protein, mg/L</td> <td>7.6 (1.6â€"31.6)</td> <td>39.3 (2.9â€"72.3)</td> <td>0.006</td> </tr> <tr> <td>Procalcitonin, ng/mL</td> <td>0.1 (0.1â€"0.1)</td> <td>0.1 (0.1â€"0.2)</td> <td>0.085</td> </tr> <tr> <td>Glucose, mmol/L</td> <td>5.7 (5.2â€"7.1)</td> <td>8.6 (6.5â€"15.6)</td> <td>&amp;lt;0.001</td> </tr> <tr> <td>HbA1c, %</td> <td>6.3 (6.0â€"6.5)</td> <td>8.1 (6.6â€"9.7)</td> <td>&amp;lt;0.001</td> </tr> <tr> <td>HbA1c, mmol/mol</td> <td>45 (42â€"48)</td> <td>65 (49â€"83)</td> <td>&amp;lt;0.001</td> </tr> <tr> <td>Prothrombin time, second</td> <td>13.5 (13.0â€"14.2)</td> <td>13.7 (13.0â€"14.3)</td> <td>0.615</td> </tr> <tr> <td>Activated partial thromboplastin time, second</td> <td>38.2 (35.8â€"42.2)</td> <td>38.5 (34.6â€"44.1)</td> <td>0.836</td> </tr> <tr> <td>D-dimer, mg/L</td> <td>0.7 (0.3â€"1.5)</td> <td>0.8 (0.4â€"1.7)</td> <td>0.422</td> </tr> <tr> <td>N-terminal brain natriuretic peptide precursor, pg/mL</td> <td>113.5 (59.3â€"300.0)</td> <td>194.5 (87.8â€"423.0)</td> <td>0.032</td> </tr> <tr> <td>Cardiac troponin I, ng/mL</td> <td>4.3 (2.3â€"9.3)</td> <td>4.9 (2.2â€"17.4)</td> <td>0.457</td> </tr> <tr> <td>Interleukin-6, pg/mL</td> <td>4.5 (2.3â€"15.8)</td> <td>6.5 (1.8â€"27.3)</td> <td>0.451</td> </tr> <tr> <td>Tumor necrosis factor-Î±, pg/mL</td> <td>8.0 (6.0â€"10.7)</td> <td>7.8 (6.1â€"10.6)</td> <td>0.740</td> </tr> <tr> <td>ICU admission</td> <td>9 (7.0%)</td> <td>11 (17.2%)</td> <td>0.030</td> </tr> <tr> <td>Immediate death</td> <td>1 (0.8%)</td> <td>1 (1.6%)</td> <td>1.000</td> </tr> <tr> <td>Worsening</td> <td>10 (7.8%)</td> <td>12 (18.8%)</td> <td>0.025</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Abbreviations: ICU, intensive care units.</p> </div> <div class="fn-type-" title=""> <p>Data are presented as numbers (%) or median [25thâ€"75th percentile].</p> </div> </div>  <p /> </div> <div class="theassociationbetweenglycemiccontrolandtheoutcomesofthepatientswithdiabetes" title="sec"><span class="label" tagx="label" title="label">3.3</span><div class="title" tagx="title" title="title">
The association between glycemic control and the outcomes of the patients with diabetes</div> <p id="p0075">Complete data collected from 64 patients with diabetes (12 in the worsening group, and 52 in the discharge group) were included in the logistic regression models (<a href="#t0015">Table 3</a> ). In the univariable analysis (Model 1), HbA1c, maximum of the BG in-hospital, lymphopenia, the percentage of neutrophils, CRP and prothrombin time were associated with worsening. In the model 2 included HbA1c and the maximum of the BG in-hospital, only HbA1c was associated with increased odds of worsening. When adjusting for lymphopenia, CRP and prothrombin time, HbA1c was still associated with increased odds of worsening. <div class="table-wrap_UNKNOWN" position="float" id="t0015"><span class="label" tagx="label" title="label">Table 3</span> </div></p><p>Bivariate logistic regression of the association between glycemic control and the risk of disease worsening.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th /> <th colspan="2">Model 1<a href="#tblfn1">a</a><hr /> </th> <th colspan="2">Model 2<a href="#tblfn2">b</a><hr /> </th> <th colspan="2">Model 3<a href="#tblfn3">c</a><hr /> </th> </tr> <tr> <th>Parameters</th> <th>OR (95%CI)</th> <th>P value</th> <th>OR (95%CI)</th> <th>P value</th> <th>OR (95%CI)</th> <th>P value</th> </tr> </thead> <tbody> <tr> <td>HbA1c, %</td> <td>2.73 (1.47â€"5.07)</td> <td align="char">0.001</td> <td>2.52 (1.31â€"4.87)</td> <td align="char">0.006</td> <td>3.29 (1.19â€"9.13)</td> <td align="char">0.022</td> </tr> <tr> <td>Maximum of the blood glucose in-hospital, mmol/L</td> <td>1.20 (1.04â€"1.39)</td> <td align="char">0.014</td> <td>1.06 (0.88â€"1.28)</td> <td align="char">0.546</td> <td>0.97 (0.75â€"1.26)</td> <td align="char">0.843</td> </tr> <tr> <td>Lymphocyte, %, &amp;lt; 20</td> <td>13.87 (1.67â€"115.43)</td> <td align="char">0.015</td> <td /> <td /> <td>2.08 (0.14â€"31.93)</td> <td align="char">0.600</td> </tr> <tr> <td>C-reactive protein, mg/L</td> <td>1.02 (1.01â€"1.03)</td> <td align="char">0.007</td> <td /> <td /> <td>1.02 (1.00â€"1.04)</td> <td align="char">0.147</td> </tr> <tr> <td>Prothrombin time, second</td> <td>3.92 (1.55â€"9.89)</td> <td align="char">0.004</td> <td /> <td /> <td>2.96 (0.75â€"11.68)</td> <td align="char">0.122</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">a</span><p id="np005">univariate analysis.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">b</span><p id="np010">multivariate analysis included HbA1c and the maximum of the blood glucose in-hospital.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">c</span><p id="np015">multivariate analysis included the variables with a P valueÂ <div class="â_UNKNOWN"> </div></p></div> </div>  <p /> <p id="p0080">Using disease worsening as the end point, ROC curve analysis was used to identify the optimal HbA1c cutoff value, which was 8.6% (70Â mmol/mol) (<a href="#f0005">Fig. 1</a> ). With this value, the area under the ROC curve was 0.90 (95% CI, 0.83â€"0.98, pÂ <div class="â_UNKNOWN" href="#t0020">
Table 4 ). Compared to the HbA1c well-controlled patients, the poorly-controlled patients presented higher white cell count and the percentage of neutrophils. Also, the incidence of lymphopenia was higher in the poorly-controlled patients. Levels of the maximum of the BG in-hospital, hemoglobin, triglyceride, urea nitrogen, prothrombin time and cTnI were clearly elevated in the poorly-controlled patients compared with the well-controlled patients. </div></p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p>The predictive value of the HbA1c level for the worsening among COVID-19 patients with diabetes.</p>   </div> <div class="table-wrap_UNKNOWN" position="float" id="t0020"><span class="label" tagx="label" title="label">Table 4</span> <p>Demographics and clinical characteristics of COVID-19 patients with diabetes in the well-controlled and poorly-controlled HbA1c groups.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th>Parameters</th> <th>HbA1cÂ â‰¤Â 8.6%<br /><br />(nÂ =Â 43)</th> <th>HbA1cÂ &amp;gt;Â 8.6%<br /><br />(nÂ =Â 21)</th> <th>P value</th> </tr> </thead> <tbody> <tr> <td>Age, years</td> <td>64.5 (58.8â€"71.0)</td> <td>67.0 (58.5â€"75.0)</td> <td>0.535</td> </tr> <tr> <td>Male gender</td> <td>21 (48.8%)</td> <td>15 (71.4%)</td> <td>0.073</td> </tr> <tr> <td>Female gender</td> <td>22 (51.2%)</td> <td>6 (28.6%)</td> <td><b>â€"â€"</b></td> </tr> <tr> <td colspan="4">Comorbidities on Admission</td> </tr> <tr> <td>Hypertension</td> <td>28 (65.1%)</td> <td>9 (42.9%)</td> <td>0.090</td> </tr> <tr> <td>Hyperlipemia</td> <td>4 (9.3%)</td> <td>1 (4.8%)</td> <td>1.000</td> </tr> <tr> <td>Chronic renal diseases</td> <td>0 (0.0%)</td> <td>0 (0.0%)</td> <td>â€"â€"</td> </tr> <tr> <td>White cell count, Ã— 10<sup>9</sup>/L</td> <td>5.7 (5.0â€"8.0)</td> <td>7.7 (6.1â€"14.1)</td> <td>0.010</td> </tr> <tr> <td>&amp;lt; 4</td> <td>5 (11.6%)</td> <td>1 (4.8%)</td> <td>0.654</td> </tr> <tr> <td>4â€"10</td> <td>31 (72.1%)</td> <td>14 (66.7%)</td> <td>â€"â€"</td> </tr> <tr> <td>&amp;gt; 10</td> <td>7 (16.3%)</td> <td>6 (28.6%)</td> <td>â€"â€"</td> </tr> <tr> <td>Neutrophils, %</td> <td>69.1 (58.7â€"78.1)</td> <td>82.4 (67.3â€"88.9)</td> <td>0.002</td> </tr> <tr> <td>Lymphocyte, %</td> <td>20.5 (13.6â€"30.0)</td> <td>11.5 (5.9â€"21.8)</td> <td>0.011</td> </tr> <tr> <td>&amp;lt; 20</td> <td>19 (44.2%)</td> <td>15 (71.4%)</td> <td>0.040</td> </tr> <tr> <td>â‰¥20</td> <td>24 (55.8%)</td> <td>6 (28.6%)</td> <td>â€"â€"</td> </tr> <tr> <td>Monocytes, %</td> <td>8.4 (7.2â€"10.3)</td> <td>7.1 (3.4â€"8.8)</td> <td>0.030</td> </tr> <tr> <td>Hemoglobin, g/L</td> <td>126.0 (112.0â€"134.0)</td> <td>137.0 (126.5â€"145.0)</td> <td>0.005</td> </tr> <tr> <td>Platelet count, Ã— 10<sup>9</sup>/L</td> <td>237.0 (196.0â€"340.0)</td> <td>214.5 (166.3â€"312.5)</td> <td>0.305</td> </tr> <tr> <td>Alanine aminotransferase, U/L</td> <td>23.0 (13.0â€"35.0)</td> <td>24.0 (16.0â€"39.5)</td> <td>0.582</td> </tr> <tr> <td>Aspartate aminotransferase, U/L</td> <td>25.0 (16.0â€"33.0)</td> <td>30.0 (20.5â€"37.0)</td> <td>0.331</td> </tr> <tr> <td>Total bilirubin, mmol/L</td> <td>7.9 (5.7â€"10.3)</td> <td>8.6 (6.1â€"17.7)</td> <td>0.131</td> </tr> <tr> <td>Alkaline phosphatase, U/L</td> <td>67.0 (54.0â€"84.0)</td> <td>69.0 (58.0â€"85.5)</td> <td>0.602</td> </tr> <tr> <td>Î³-glutamyl transferase, U/L</td> <td>27.0 (16.0â€"66.0)</td> <td>28.0 (19.0â€"65.5)</td> <td>0.932</td> </tr> <tr> <td>Total cholesterol, mmol/L</td> <td>3.7 (3.2â€"4.3)</td> <td>3.8 (3.1â€"5.0)</td> <td>0.516</td> </tr> <tr> <td>Triglyceride, mmol/L</td> <td>1.1 (0.9â€"1.7)</td> <td>1.8 (1.6â€"2.6)</td> <td>0.010</td> </tr> <tr> <td>Creatinine, Î¼mol/L</td> <td>67.0 (52.0â€"81.0)</td> <td>74.0 (61.0â€"112.5)</td> <td>0.141</td> </tr> <tr> <td>Urea nitrogen, mmol/L</td> <td>5.0 (3.6â€"5.9)</td> <td>6.5 (4.5â€"9.7)</td> <td>0.016</td> </tr> <tr> <td>C-reactive protein, mg/L</td> <td>22.9 (2.0â€"64.4)</td> <td>46.9 (15.7â€"125.7)</td> <td>0.110</td> </tr> <tr> <td>Procalcitonin, ng/mL</td> <td>0.1 (0.1â€"0.1)</td> <td>0.1 (0.1â€"0.4)</td> <td>0.306</td> </tr> <tr> <td>Glucose, mmol/L</td> <td>7.6 (6.1â€"11.7)</td> <td>12.6 (8.1â€"19.3)</td> <td>0.010</td> </tr> <tr> <td>HbA1c, %</td> <td>7.3 (6.8â€"7.6)</td> <td>9.4 (9.1â€"10.2)</td> <td>&amp;lt;0.001</td> </tr> <tr> <td>HbA1c, mmol/mol</td> <td>56 (51â€"60)</td> <td>79 (76â€"88)</td> <td>&amp;lt;0.001</td> </tr> <tr> <td>Maximum of the glucose in-hospital, mmol/L</td> <td>8.3 (6.6â€"12.3)</td> <td>12.0 (8.8â€"16.5)</td> <td>0.002</td> </tr> <tr> <td>Prothrombin time, second</td> <td>13.4 (12.8â€"14.0)</td> <td>13.9 (13.4â€"15.5)</td> <td>0.015</td> </tr> <tr> <td>Activated partial thromboplastin time, second</td> <td>38.2 (34.3â€"41.9)</td> <td>40.3 (35.3â€"48.0)</td> <td>0.153</td> </tr> <tr> <td>D-dimer, mg/L</td> <td>0.7 (0.4â€"1.6)</td> <td>1.2 (0.6â€"2.2)</td> <td>0.217</td> </tr> <tr> <td>N-terminal brain natriuretic peptide precursor, pg/mL</td> <td>166.5 (82.0â€"396.8)</td> <td>388.5 (97.0â€"983.5)</td> <td>0.230</td> </tr> <tr> <td>Cardiac troponin I, ng/mL</td> <td>3.8 (1.9â€"7.6)</td> <td>13.8 (3.0â€"36.8)</td> <td>0.011</td> </tr> <tr> <td>Interleukin-6, pg/mL</td> <td>4.8 (1.6â€"27.5)</td> <td>12.0 (2.3â€"24.3)</td> <td>0.605</td> </tr> <tr> <td>Tumor necrosis factor-Î±, pg/mL</td> <td>7.3 (4.5â€"10.0)</td> <td>8.9 (6.9â€"10.9)</td> <td>0.083</td> </tr> <tr> <td>ICU admission</td> <td>0 (0.0%)</td> <td>11 (52.4%)</td> <td>&amp;lt;0.001</td> </tr> <tr> <td>Immediate death</td> <td>0 (0.0%)</td> <td>1 (4.8%)</td> <td>0.328</td> </tr> <tr> <td>Worsening</td> <td>0 (0.0%)</td> <td>12 (57.1%)</td> <td>&amp;lt;0.001</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Abbreviations: ICU, intensive care units.</p> </div> <div class="fn-type-" title=""> <p>Data are presented as numbers (%) or median [25thâ€"75th percentile].</p> </div> </div> </div> <p /> </div> <div class="theassociationbetweentheuseofantidiabetic/antihypertensivedrugsandtheoutcomes" title="sec"><span class="label" tagx="label" title="label">3.4</span><div class="title" tagx="title" title="title">
The association between the use of antidiabetic/antihypertensive drugs and the outcomes</div> <p id="p0085">Of the 64 patients with diabetes, 52 (81.3%) patients received antidiabetic treatment during hospitalization, including metformin (18/52 [34.6%]), insulin (22/52 [42.3%]), Î±-glucosidase inhibitors (26/52 [50.0%]), pioglitazone (6/52 [11.5%]), sulfonylureas (6/52 [11.5%]), dipeptidyl peptidase-4 inhibitors (6/52 [11.5%]). 36 (56.3%) patients received antihypertensive treatment during hospitalization, including ACEIs/ARBs (14/36 [38.9%]), calcium channel blockers (CCBs) (27/36 [75.0%]), Î²-receptor blockers(9/36 [25.0%]), spironolactone (4/36 [11.1%]). Moreover, 10 (10/64 [15.6%]) patients received statins therapy. The association between the use of antidiabetic/antihypertensive drugs and disease worsening was shown in Supplementary <a href="#t0005">Table 1</a>. Drugs with fewer users were not analyzed. Results demonstrated that Î±-glucosidase inhibitors and CCBs use were significantly associated with decreased odds of disease worsening. After adjusting for glucose, HbA1c at admission and maximum of the glucose in-hospital, there were no significant associations between the use of metformin, insulin, ACEIs/ARBs, statins and disease worsening.</p> </div> </div> <div class="discussion" title="sec"><span class="label" tagx="label" title="label">4</span><div class="title" tagx="title" title="title">
Discussion</div> <p id="p0090">This retrospective cohort study have 3 novel findings with important implications for the COVID-19 patients with diabetes. First of all, not only did we find that COVID-19 patients with pre-existing DM had an increased risk of disease worsening, but poor previous glycemic control, which was reflected by HbA1c, was associated with higher odds of disease worsening. Second, to our knowledge, this was the first study investigating the prognostic value of HbA1c in the COVID-19 patients with diabetes, and a HbA1c level of 8.6% (70Â mmol/mol) was the optimal cutoff value. Furthermore, we found that Î±-glucosidase inhibitors and CCBs use were associated with reduced odds of disease worsening. Metformin, insulin, ACEIs/ARBs and statins were not associated with the worsening of COVID-19 in the patients with diabetes. These findings could help frontline medical doctors predict the prognosis of COVID-19 patients according to their previous history of DM and the level of HbA1c, and choose appropriate antidiabetic/antihypertensive therapy for the patients with diabetes.</p> <p id="p0095">Previously, the prognosis of COVID-19 patients with pre-existing DM has been reported. The majority of the studies demonstrated that diabetes was an important risk factor for the progression or mortality in COVID-19 <a href="#b0020">[4]</a>, <a href="#b0045">[9]</a>, <a href="#b0050">[10]</a>, while some reported that COVID-19 patients with diabetes seemed not to have a higher mortality risk <a href="#b0055">[11]</a>, <a href="#b0060">[12]</a>. A recent <i>meta</i>-analysis involving 4 studies suggested that COVID-19 patients with diabetes had an increased risk of ICU admission and mortality <a href="#b0100">[20]</a>, which was consistent with the results in our study. It is worth noting that the judgement of pre-existing diabetes was based on the patientâ€™s self-report at admission, which could lead to the underdiagnosis of diabetes in the control group. In fact, the median level of HbA1c in the control group was 6.3%, which was above the normal upper limit of HbA1c (6.0%). Thus, although our results showed an increased risk of disease worsening in COVID-19 patients with diabetes, the risk might still be underestimated.</p> <p id="p0100">HbA1c is considered to be a good indicator reflecting long-term glycemia <a href="#b0105">[21]</a>. Previous studies have reported that patients with poor HbA1c control were more susceptible to infections, such as the infections of <i>Chlamydia pneumoniae</i>, hemolytic streptococci groups B, G, <i>Klebsiella pneumoniae</i>, <i>Mycobacterium tuberculosis</i>, and exhibited worse prognosis compared to the patients with well HbA1c control <a href="#b0110">[22]</a>, <a href="#b0115">[23]</a>, <a href="#b0120">[24]</a>, <a href="#b0125">[25]</a>. Besides, chronic hyperglycemia was thought to downregulate ACE-2 expression, making cells susceptible to the damage of SARS-CoV-2 <a href="#b0130">[26]</a>. However, to our knowledge, the association between HbA1c level and the prognosis of COVID-19 patients with diabetes has not been explored. Our study found that among COVID-19 patients, those with poor HbA1c control had a higher risk of disease worsening, with an optimal cut-off value of 8.6% (70Â mmol/mol), demonstrating the importance of previous glycemic control. Furthermore, we compared the clinical characteristics of the HbA1c well-controlled group with the poorly-controlled group. The HbA1c poorly-controlled patients presented a higher incidence of lymphopenia (71.4% versus 44.2%) compared to the well-controlled patients. Also, the levels of the percentage of neutrophils, prothrombin time and cTnI were significantly elevated in the poorly-controlled group. The changes in these clinical indicators were consistent with those in the COVID-19 severe cases that have been reported previously <a href="#b0020">[4]</a>, <a href="#b0055">[11]</a>, <a href="#b0135">[27]</a>, suggesting that the higher risk of disease worsening in the poorly-controlled group might be associated with the changes in these clinical indicators in addition to the poor glycemic control.</p> <p id="p0105">The association between the in-hospital use of common antidiabetic/antihypertensive drugs and the prognosis of the COVID-19 patients with diabetes was also explored in this study for the first time. The results demonstrated that Î±-glucosidase inhibitors and CCBs use were associated with a lower risk of disease worsening, and no significant associations were observed between the use of metformin, insulin, ACEIs/ARBs, statins and disease worsening after adjusting for glucose, HbA1c at admission and maximum of the glucose in-hospital. Previous studies demonstrated that ACE-2 Ser680 residue could be phosphorylated to improve the stability and increase the expression of ACE-2 in human umbilical vein endothelial cells by the 5â€²-AMP-activated protein kinase, which was the molecular effector of the majority of metforminâ€™s pharmacological actions <a href="#b0085">[17]</a>. Special considerations were also recommended on the use of metformin due to the lactic acidosis associated with it <a href="#b0130">[26]</a>. In addition, previous studies reported that ACEIs/ARBs could upregulate the ACE-2 expression, which might facilitate the entry and proliferation of SARS-CoV-2 <a href="#b0065">[13]</a>, <a href="#b0140">[28]</a>. Thus, there are concerns about the safety of using ACEIs/ARBs in patients with diabetes. Our results demonstrated that there were no significant associations between the use of metformin, insulin, Î±-glucosidase inhibitors, ACEIs/ARBs, CCBs, statins and increased odds of disease worsening. Even the use of Î±-glucosidase inhibitors and CCBs were significantly associated with decreased odds of disease worsening. Although the potential bias of reverse causation cannot be ruled out, our results at least suggested that the use of these drugs were not associated with a higher risk of disease worsening. However, considering the risk of acute metabolic decompensation caused by metformin in COVID-19 patients with severe symptoms as well as the fact that the maximum of the in-hospital BG alone cannot fully reflect the in-hospital glycemic control, the safety of the in-hospital use of metformin needs more studies to explore.</p> <p id="p0110">There were some limitations of our study. First, the interpretation of our results might be limited by the sample size. Second, owing to the retrospective design of the study, the lack of data didnâ€™t allow us to analyze the type of DM, disease course and mean in-hospital BG. Third, due to the lack of mean in-hospital BG resulting from the urgency of pandemic, only the maximum of the in-hospital BG could be used to reflect the in-hospital glycemic control, which could reduce the convictive power of the conclusions about the safety of antidiabetic/antihypertensive drugs. In the urgent conditions, medical history was not taken in detail and some laboratory examinations were not performed in all patients.</p> </div> <div class="conclusions" title="sec"><span class="label" tagx="label" title="label">5</span><div class="title" tagx="title" title="title">
Conclusions</div> <p id="p0115">COVID-19 patients with pre-existing DM had an increased risk of disease worsening, especially those with poorly-controlled HbA1c, with an optimal cut-off value of 8.6% (70Â mmol/mol). The in-hospital use of common antidiabetic/antihypertensive drugs were not associated with a higher risk of disease worsening in COVID-19 patients with diabetes.</p> </div> <div class="ethicsapprovalandconsenttoparticipate" title="sec"><span class="label" tagx="label" title="label">6</span><div class="title" tagx="title" title="title">
Ethics approval and consent to participate</div> <p id="p0120">Ethical approval for this study was granted by the Ethics Committee of Tongji Hospital (TJ-IRB20200404). Written informed consent was waived due to the urgency of pandemic.</p> </div> <div class="data-availability" title="data-availability"><span class="label" tagx="label" title="label">7</span><div class="title" tagx="title" title="title">
Data availability</div> <p id="p0125">The dataset used during the current study are available from the corresponding author on reasonable request.</p> </div> <div class="contributionstatement" title="sec"><span class="label" tagx="label" title="label">8</span><div class="title" tagx="title" title="title">
Contribution statement</div> <p id="p0130">All authors read and approved the final manuscript. SC and XY designed the study. ZL and XH collected data. XB conducted the analysis and wrote the first draft. WJ and LQ finalized the manuscript. The corresponding authors attests that all listed authors meet the authorship criteria and that no others meeting the criteria have been omitted.</p> </div> <div class="funding" title="sec"> <div class="title" tagx="title" title="title">
Funding</div> <p id="p0135">This study was supported by the following funding: National Major Scientific and Technological Special Project for â€œSignificant New Drugs Developmentâ€� (grant number 2017ZX09304022); China Ying-cai Young Scientific Talent Research Project (grant number 2017-N-07).</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Declaration of Competing Interest</div> <p id="p0140">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="b0005" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Organization, W.H.: Coronavirus disease (COVID-19) Situation dashboard. https://who.sprinklr.com/ (2020). Accessed 2 July 2020</span></li> <li tag="ref"><a name="b0010" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McGoogan</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention</span><span class="source" tagx="source" title="source">JAMA</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1001/jama.2020.2648">10.1001/jama.2020.2648</a></span></span></li> <li tag="ref"><a name="b0015" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gong</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</span><span class="source" tagx="source" title="source">Lancet (London, England)</span><span class="volume" tagx="volume" title="volume">395</span><span class="issue" tagx="issue" title="issue">10223</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">507</span><span class="lpage" tagx="lpage" title="lpage">513</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/s0140-6736(20)30211-7">10.1016/s0140-6736(20)30211-7</a></span></span></li> <li tag="ref"><a name="b0020" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</span><span class="source" tagx="source" title="source">Lancet (London, England)</span><span class="volume" tagx="volume" title="volume">395</span><span class="issue" tagx="issue" title="issue">10229</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1054</span><span class="lpage" tagx="lpage" title="lpage">1062</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/s0140-6736(20)30566-3">10.1016/s0140-6736(20)30566-3</a></span></span></li> <li tag="ref"><a name="b0025" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span><span class="source" tagx="source" title="source">Lancet (London, England)</span><span class="volume" tagx="volume" title="volume">395</span><span class="issue" tagx="issue" title="issue">10223</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">497</span><span class="lpage" tagx="lpage" title="lpage">506</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/s0140-6736(20)30183-5">10.1016/s0140-6736(20)30183-5</a></span></span></li> <li tag="ref"><a name="b0030" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singh</span><span class="given-names" tagx="given-names" title="given-names">A.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gupta</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghosh</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Misra</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations</span><span class="source" tagx="source" title="source">Diabet Metabolic Syndrome</span><span class="volume" tagx="volume" title="volume">14</span><span class="issue" tagx="issue" title="issue">4</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">303</span><span class="lpage" tagx="lpage" title="lpage">310</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.dsx.2020.04.004">10.1016/j.dsx.2020.04.004</a></span></span></li> <li tag="ref"><a name="b0035" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">M.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">S.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fu</span><span class="given-names" tagx="given-names" title="given-names">H.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">B.Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS</span><span class="source" tagx="source" title="source">Diabet Med J British Diabet Assoc</span><span class="volume" tagx="volume" title="volume">23</span><span class="issue" tagx="issue" title="issue">6</span><span class="year" tagx="year" title="year">2006</span><span class="fpage" tagx="fpage" title="fpage">623</span><span class="lpage" tagx="lpage" title="lpage">628</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1464-5491.2006.01861.x">10.1111/j.1464-5491.2006.01861.x</a></span></span></li> <li tag="ref"><a name="b0040" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Tawfiq</span><span class="given-names" tagx="given-names" title="given-names">J.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hinedi</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghandour</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khairalla</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Musleh</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ujayli</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients</span><span class="source" tagx="source" title="source">Clin Infect Dis Off Publicat Infect. Dis Soc America</span><span class="volume" tagx="volume" title="volume">59</span><span class="issue" tagx="issue" title="issue">2</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">160</span><span class="lpage" tagx="lpage" title="lpage">165</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/cid/ciu226">10.1093/cid/ciu226</a></span></span></li> <li tag="ref"><a name="b0045" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., Zhao, L., Fan, H., Luo, S., Hu, D.: Diabetes is a risk factor for the progression and prognosis of COVID-1Diabetes/metabolism research and reviews, e3319 (2020). doi:10.1002/dmrr.3319</span></li> <li tag="ref"><a name="b0050" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xue</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study</span><span class="source" tagx="source" title="source">PLoS NeglTrop Dis</span><span class="volume" tagx="volume" title="volume">14</span><span class="issue" tagx="issue" title="issue">5</span><span class="year" tagx="year" title="year">2020</span>e0008280<span class="pub-id"><a href="https://dx.doi.org/10.1371/journal.pntd.0008280">10.1371/journal.pntd.0008280</a></span></span></li> <li tag="ref"><a name="b0055" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan China</span><span class="source" tagx="source" title="source">JAMA Internal Med</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1001/jamainternmed.2020.0994">10.1001/jamainternmed.2020.0994</a></span></span></li> <li tag="ref"><a name="b0060" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</span><span class="source" tagx="source" title="source">Lancet Respirat Med</span><span class="volume" tagx="volume" title="volume">8</span><span class="issue" tagx="issue" title="issue">5</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">475</span><span class="lpage" tagx="lpage" title="lpage">481</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/s2213-2600(20)30079-5">10.1016/s2213-2600(20)30079-5</a></span></span></li> <li tag="ref"><a name="b0065" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pal</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhansali</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">COVID-19, diabetes mellitus and ACE2: The conundrum</span><span class="source" tagx="source" title="source">Diabet Res Clin Pract</span><span class="volume" tagx="volume" title="volume">162</span><span class="year" tagx="year" title="year">2020</span>108132<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.diabres.2020.108132">10.1016/j.diabres.2020.108132</a></span></span></li> <li tag="ref"><a name="b0070" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gupta</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghosh</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singh</span><span class="given-names" tagx="given-names" title="given-names">A.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Misra</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical considerations for patients with diabetes in times of COVID-19 epidemic</span><span class="source" tagx="source" title="source">Diabet Metabolic Syndrome</span><span class="volume" tagx="volume" title="volume">14</span><span class="issue" tagx="issue" title="issue">3</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">211</span><span class="lpage" tagx="lpage" title="lpage">212</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.dsx.2020.03.002">10.1016/j.dsx.2020.03.002</a></span></span></li> <li tag="ref"><a name="b0075" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Badawi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ryoo</span><span class="given-names" tagx="given-names" title="given-names">S.G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis</span><span class="source" tagx="source" title="source">J Public Health Res</span><span class="volume" tagx="volume" title="volume">5</span><span class="issue" tagx="issue" title="issue">3</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">733</span><span class="pub-id"><a href="https://dx.doi.org/10.4081/jphr.2016.733">10.4081/jphr.2016.733</a></span></span></li> <li tag="ref"><a name="b0080" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">She</span><span class="given-names" tagx="given-names" title="given-names">Z.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qin</span><span class="given-names" tagx="given-names" title="given-names">J.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">X.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes</span><span class="source" tagx="source" title="source">Cell Metab</span><span class="volume" tagx="volume" title="volume">31</span><span class="issue" tagx="issue" title="issue">6</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1068</span><span class="lpage" tagx="lpage" title="lpage">1077.e1063</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cmet.2020.04.021">10.1016/j.cmet.2020.04.021</a></span></span></li> <li tag="ref"><a name="b0085" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martin</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gongol</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marin</span><span class="given-names" tagx="given-names" title="given-names">T.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension</span><span class="source" tagx="source" title="source">Am J Respir Crit Care Med</span><span class="volume" tagx="volume" title="volume">198</span><span class="issue" tagx="issue" title="issue">4</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">509</span><span class="lpage" tagx="lpage" title="lpage">520</span><span class="pub-id"><a href="https://dx.doi.org/10.1164/rccm.201712-2570OC">10.1164/rccm.201712-2570OC</a></span></span></li> <li tag="ref"><a name="b0090" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pal</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhadada</span><span class="given-names" tagx="given-names" title="given-names">S.K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?</span><span class="source" tagx="source" title="source">Diabetes Res Clin Pract</span><span class="volume" tagx="volume" title="volume">163</span><span class="year" tagx="year" title="year">2020</span>108146<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.diabres.2020.108146">10.1016/j.diabres.2020.108146</a></span></span></li> <li tag="ref"><a name="b0095" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">China, N.H.C.o.: New coronavirus pneumonia prevention and control program (5th edition) (in Chinese). (2020). Accessed 26 February 2020. <a href="http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf">http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf</a>.</span></li> <li tag="ref"><a name="b0100" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roncon</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zuin</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rigatelli</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zuliani</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome</span><span class="source" tagx="source" title="source">J Clin Virol Off Publicat Pan American Soc Clin Virol</span><span class="volume" tagx="volume" title="volume">127</span><span class="year" tagx="year" title="year">2020</span>104354<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jcv.2020.104354">10.1016/j.jcv.2020.104354</a></span></span></li> <li tag="ref"><a name="b0105" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rowley</span><span class="given-names" tagx="given-names" title="given-names">K.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Daniel</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">O'Dea</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease</span><span class="source" tagx="source" title="source">Diabet Med J British Diabet Assoc</span><span class="volume" tagx="volume" title="volume">22</span><span class="issue" tagx="issue" title="issue">7</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">833</span><span class="lpage" tagx="lpage" title="lpage">839</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1464-5491.2005.01447.x">10.1111/j.1464-5491.2005.01447.x</a></span></span></li> <li tag="ref"><a name="b0110" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rizzo</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paolillo</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Iafusco</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prisco</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Romano Carratelli</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Chlamydia pneumoniae infection in adolescents with type 1 diabetes mellitus</span><span class="source" tagx="source" title="source">J Med Microbiol</span><span class="volume" tagx="volume" title="volume">61</span><span class="issue" tagx="issue" title="issue">Pt 11</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">1584</span><span class="lpage" tagx="lpage" title="lpage">1590</span><span class="pub-id"><a href="https://dx.doi.org/10.1099/jmm.0.048512-0">10.1099/jmm.0.048512-0</a></span></span></li> <li tag="ref"><a name="b0115" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thomsen</span><span class="given-names" tagx="given-names" title="given-names">R.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riis</span><span class="given-names" tagx="given-names" title="given-names">A.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kjeldsen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SchÃ¸nheyder</span><span class="given-names" tagx="given-names" title="given-names">H.C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G</span><span class="source" tagx="source" title="source">J Infect</span><span class="volume" tagx="volume" title="volume">63</span><span class="issue" tagx="issue" title="issue">1</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">8</span><span class="lpage" tagx="lpage" title="lpage">16</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jinf.2011.05.013">10.1016/j.jinf.2011.05.013</a></span></span></li> <li tag="ref"><a name="b0120" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">C.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">I.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chuah</span><span class="given-names" tagx="given-names" title="given-names">S.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tai</span><span class="given-names" tagx="given-names" title="given-names">W.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chang</span><span class="given-names" tagx="given-names" title="given-names">C.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">F.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Impact of glycemic control on capsular polysaccharide biosynthesis and opsonophagocytosis of Klebsiella pneumoniae: Implications for invasive syndrome in patients with diabetes mellitus</span><span class="source" tagx="source" title="source">Virulence</span><span class="volume" tagx="volume" title="volume">7</span><span class="issue" tagx="issue" title="issue">7</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">770</span><span class="lpage" tagx="lpage" title="lpage">778</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/21505594.2016.1186315">10.1080/21505594.2016.1186315</a></span></span></li> <li tag="ref"><a name="b0125" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">L.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">S.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shao</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis</span><span class="source" tagx="source" title="source">Infect Drug Resistance</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">187</span><span class="lpage" tagx="lpage" title="lpage">193</span><span class="pub-id"><a href="https://dx.doi.org/10.2147/idr.S146741">10.2147/idr.S146741</a></span></span></li> <li tag="ref"><a name="b0130" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bornstein</span><span class="given-names" tagx="given-names" title="given-names">S.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rubino</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khunti</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mingrone</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hopkins</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Birkenfeld</span><span class="given-names" tagx="given-names" title="given-names">A.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Practical recommendations for the management of diabetes in patients with COVID-19</span><span class="source" tagx="source" title="source">Lancet Diabet Endocrinol</span><span class="volume" tagx="volume" title="volume">8</span><span class="issue" tagx="issue" title="issue">6</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">546</span><span class="lpage" tagx="lpage" title="lpage">550</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/s2213-8587(20)30152-2">10.1016/s2213-8587(20)30152-2</a></span></span></li> <li tag="ref"><a name="b0135" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wan</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical features and treatment of COVID-19 patients in northeast Chongqing</span><span class="source" tagx="source" title="source">J Med Virol</span><span class="volume" tagx="volume" title="volume">92</span><span class="issue" tagx="issue" title="issue">7</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">797</span><span class="lpage" tagx="lpage" title="lpage">806</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jmv.25783">10.1002/jmv.25783</a></span></span></li> <li tag="ref"><a name="b0140" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cure</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cumhur Cure</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic</span><span class="source" tagx="source" title="source">Diabet Metabolic Syndrome</span><span class="volume" tagx="volume" title="volume">14</span><span class="issue" tagx="issue" title="issue">4</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">349</span><span class="lpage" tagx="lpage" title="lpage">350</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.dsx.2020.04.019">10.1016/j.dsx.2020.04.019</a></span></span></li> </ul> </div> <div class="supplementary-material" title="supplementary-material"><span class="label" tagx="label" title="label">Appendix A</span><div class="title" tagx="title" title="title">
Supplementary material</div> <p id="p0155">The following are the Supplementary data to this article: </p><div class="local-data" title="local-data">  <div class="title" tagx="title" title="title">
Supplementary data 1</div>  <div class="media" title="media"><a href="mmc1.docx">LINK</a></div> </div> <p /> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>Not applicable.</p> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-supplementary-material" title="supplementary-material"><span class="label" tagx="label" title="label">Appendix A</span><p id="p0150">Supplementary data to this article can be found online at <a href="https://doi.org/10.1016/j.diabres.2020.108386">https://doi.org/10.1016/j.diabres.2020.108386</a>.</p> </div> </div> </div>  </body></html>